Biologic anti-IL17 drugs in erythrodermic psoriasisCapsule Summary

• Main Authors: Alessandro Falco, MD (Author), Cristina Mugheddu, MD (Author), Jasmine Anedda, MD (Author), Laura Pizzatti, MD (Author), Alice Tatti, MD (Author), Brunella Conti, MD (Author), Laura Atzori, MD (Author)
• Format: Book
• Published: Elsevier, 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Erythrodermic psoriasis (EP) is a potentially life-threatening disease, and there is currently no consensus regarding its optimal treatment. Biological drugs approved for Psoriasis Vulgaris treatment have been used as alternatives to traditional medications. Objective: To evaluate the cl...